Deutsches Herzzentrum Berlin

At Deutsches Herzzentrum Berlin, cardiovascular studies focus on heart disease, acute coronary syndromes, myocardial infarction, heart failure, and atrial fibrillation. The trials are designed to test new treatments, improve prevention strategies, and better understand outcomes after cardiac surgery or major cardiac events.

• Prevention of stroke and systemic embolism in atrial fibrillation
• Therapies for acute myocardial infarction and recovery after STEMI
• Treatment options for heart failure and pulmonary hypertension
• Strategies to reduce cardiovascular risk in atherosclerotic cardiovascular disease

Several studies also explore better ways to support patients after surgery and to assess whether newer medicines can improve long-term heart function and survival.

This site conducts extensive research in cancer and blood disorders, including lung cancer, gastric cancer, hepatocellular carcinoma, ovarian cancer, acute myeloid leukemia, and lymphoma. The studies mainly aim to evaluate new therapies, compare treatment combinations, and improve survival outcomes.

• New treatment approaches for non-small cell lung cancer and small cell lung cancer
• Research in acute myeloid leukemia, myelodysplastic syndromes, and pediatric leukemias
• Studies in gastroesophageal, pancreatic, and head and neck cancers
• Trials for Ewing sarcoma, neuroblastoma, and other childhood tumors

The oncology program includes both adult and pediatric populations, with a strong emphasis on testing immunotherapy, targeted therapy, and combination treatment strategies.

Clinical trials in liver disease and gastrointestinal disease address cirrhosis, hepatitis D, acute-on-chronic liver failure, hepatic encephalopathy, primary sclerosing cholangitis, and inflammatory bowel disease. These studies are focused on improving symptom control, slowing disease progression, and evaluating new treatment options.

• Therapies for metabolic liver disease such as NASH and MASH
• Treatments for ulcerative colitis and Crohn's disease
• Studies in biliary atresia and alpha-1 antitrypsin deficiency-associated liver disease
• Research on pruritus linked to primary sclerosing cholangitis

At this Berlin site, investigators are also examining how to better predict liver-related outcomes and support patients with complex digestive and metabolic conditions.

Trials in respiratory disease, allergy, and immune-related conditions include cystic fibrosis, bronchiectasis, food allergy, and systemic lupus erythematosus. The main purpose is to evaluate long-term safety, improve symptom control, and test new ways to manage chronic inflammatory disease.

• Studies in cystic fibrosis and bronchiectasis
• Research on food allergy and immune tolerance
• Trials for systemic lupus erythematosus and other immune-mediated disorders
• Evaluation of treatments for respiratory tract infection and chronic airway disease

These projects reflect a broad interest in chronic inflammation, immune regulation, and supportive care for patients with long-term respiratory and allergic conditions.

Research at the Deutsches Herzzentrum Berlin also includes a strong pediatric and rare-disease portfolio, covering congenital disorders, growth conditions, metabolic diseases, and genetic syndromes. The trials are intended to improve treatment options for children and adolescents living with uncommon or complex illnesses.

• Studies in achondroplasia, congenital hyperinsulinism, and Duchenne muscular dystrophy
• Trials for pediatric hemophilia and children's cancers
• Research on cystic fibrosis in younger populations
• Investigations into rare inherited and developmental conditions

These studies aim to support safer, more effective care for younger patients while addressing diseases that often have limited treatment choices.

The site’s cardiac anesthesiology and intensive care medicine expertise supports trials in critical illness, open-heart surgery, and advanced diagnostic techniques. Research here often evaluates whether new approaches can improve recovery, reduce complications, or help clinicians diagnose disease more accurately.

• Studies in intensive care unit populations and severe illness
• Trials supporting outcomes after cardiac surgery
• Evaluation of diagnostic imaging and biomarker-based tools
• Research on treatment effectiveness in complex hospitalized patients

This mix of studies shows a practical focus on improving care for high-risk patients and strengthening decision-making in acute clinical settings.